D2-blockade and possible ziprasidone-induced galactorrhea

International Clinical Psychopharmacology

Volumn 20, Issue 2, 2005, Pages 113-114

  Ramadan, Mohamed ^a   Khan, Ahsan ^a   Preskorn, Sheldon ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

Author keywords

D2; Galactorrhea; Ziprasidone

Indexed keywords

DOPAMINE 2 RECEPTOR; ESCITALOPRAM; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOPAMINE RECEPTOR BLOCKING; DRUG EFFECT; DRUG POTENCY; DRUG RESPONSE; FEMALE; GALACTORRHEA; HUMAN; MAJOR DEPRESSION; PRIORITY JOURNAL; PSYCHOSIS; RECURRENT DISEASE; SEDATION; SIDE EFFECT; SYMPTOM; TREATMENT OUTCOME; WEIGHT GAIN; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; MALE; PSYCHOLOGICAL RATING SCALE;

ADULT; ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER, MAJOR; DOPAMINE ANTAGONISTS; GALACTORRHEA; HUMANS; MALE; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, DOPAMINE D2; THIAZOLES;

EID: 14844349119     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200503000-00009     Document Type: Article

References (9)

1. Bench CJ, Lammertsma AA, Dolan RJ, Grasby PM, Warrington SJ, Gunn K, et al. (1993). Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88, 050-01: a study using positron emission tomography and 11C-racioprid. Psychopharmacology (Berl) 112:308-314.
2. Clutter WE (2001). Endocrine diseases. In: Ahya SN, Flood K, Paranjothi S (editors): The Washington Manual of Medical Theraputics, 30th edn. Baltimore, Maryland: Lippincott Williams & Wilkins, pp. 473-490.
3. Goodnick PJ (2002). Antisychotics: impact on prolactin levels. Exp Opin Pharmacother 3:1381-1391.
4. Jordan MP (2003). Ziprasidone-associated galactorrhea in a female teenager. J Am Acad Child Adolesc Psychiatry 42:4-5.
5. Kapur S, Seeman P (2001). Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry 153:360-369.
6. Kapur S, Zipursky R, Jones C, Shammi CS, Remington G, Seeman P (2000). A positron emission tomography study of quetiapine in schizophrenia. Arch Gen Psychiatry 57:553-559.
7. Petty RG (1999). Prolactin and antipsychotic medications: mechanism of action. Schizophr Res 35 (suppl):S67-S73.
8. Preskorn SH (2003). Classification of neuropsychiatrie medications by principal mechanism of action: a meaningful way to anticipate pharmacodynamically mediated drug interactions. J Psychiatr Pract 9:376-384.
9. Smith S (2003). Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice. J Clin Psychopharmacol 23 (suppl):S27-S32.